Clinical Trials Browser

Phase 2 × Has results × Hereditary leiomyomatosis and renal cell cancer × Clear all

NCT01130519 2025-02-21

A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer

Phase 2 Completed

83 enrolled 17 charts

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, Kidney Neoplasms

NCT00971620 2017-04-07

Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin

Phase 2 Completed

18 enrolled 22 charts

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell